| Literature DB >> 30426722 |
Richie P Goulding1, Denise M Roche1, Simon Marwood1.
Abstract
We have previously demonstrated that the phase II time constant of pulmonary oxygen uptake kinetics ( τ v ˙ o 2 ) is an independent determinant of critical power (CP) when O2 availability is not limiting, that is, during upright cycle exercise in young, healthy individuals. Whether this causative relationship remains when O2 availability is impaired remains unknown. During supine exercise, which causes an O2 availability limitation during the exercise transition, we therefore determined the impact of a raised baseline work rate on τ v ˙ o 2 and CP. CP, τ v ˙ o 2 , and muscle oxygenation status (the latter via near-infrared spectroscopy) were determined via four severe-intensity constant-power exercise tests completed in two conditions: (1) with exercise initiated from an unloaded cycling baseline (U→S), and (2) with exercise initiated from a moderate-intensity baseline work rate of 90% of the gas exchange threshold (M→S). In M→S, critical power was lower (U→S = 146 ± 39 W vs. M→S = 132 ± 33 W, P = 0.023) and τ v ˙ o 2 was greater (U→S = 45 ± 16 sec, vs. M→S = 69 ± 129 sec, P = 0.001) when compared to U→S. There was no difference in tissue oxyhemoglobin concentration ([HbO2 + MbO2 ]) at baseline or during exercise. The concomitant increase in τ v ˙ o 2 and reduction in CP during M→S compared to U→S shows for the first time that τ v ˙ o 2 is an independent determinant of CP in conditions where O2 availability is limiting.Entities:
Keywords: Critical power; exercise tolerance; oxidative metabolism; oxygen uptake kinetics; power-duration relationship; work-to-work exercise
Mesh:
Substances:
Year: 2018 PMID: 30426722 PMCID: PMC6234148 DOI: 10.14814/phy2.13916
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Figure 1Group relationship between subcutaneous adipose tissue thickness (ATT) and resting total hemoglobin ([THb + Mb]) measured by NIRS in the rectus femoris (RF) and vastus lateralis (VL). Normalization procedure is detailed in the Methods section.
Pulmonary oxygen uptake responses to severe‐intensity constant work‐rate exercise in each condition
| Parameter | U→S | M→S |
|---|---|---|
|
| ||
| WR 1 | 0.76 ± 0.11 | 1.58 ± 0.11 |
| WR 2 | 0.88 ± 0.32 | 1.52 ± 0.10 |
| WR 3 | 0.82 ± 0.11 | 1.45 ± 0.29 |
| WR 4 | 0.80 ± 0.11 | 1.43 ± 0.28 |
|
| ||
| WR 1 | 13 ± 10 | 12 ± 14 |
| WR 2 | 9 ± 7 | 8 ± 4 |
| WR 3 | 11 ± 7 | 7 ± 9 |
| WR 4 | 11 ± 6 | 6 ± 9 |
|
| ||
| WR 1 | 43 ± 15 | 69 ± 39 |
| WR 2 | 48 ± 15 | 67 ± 23 |
| WR 3 | 43 ± 14 | 74 ± 33 |
| WR 4 | 46 ± 15 | 66 ± 20 |
|
| ||
| WR 1 | 1.49 ± 0.52 | 0.84 ± 0.43 |
| WR 2 | 1.56 ± 0.59 | 1.03 ± 0.40 |
| WR 3 | 1.69 ± 0.57 | 1.31 ± 0.52 |
| WR 4 | 1.86 ± 0.48 | 1.48 ± 0.42 |
| Absolute | ||
| WR 1 | 2.26 ± 0.52 | 2.42 ± 0.42 |
| WR 2 | 2.41 ± 0.56 | 2.55 ± 0.42 |
| WR 3 | 2.55 ± 0.48 | 2.68 ± 0.48 |
| WR 4 | 2.66 ± 0.43 | 2.71 ± 0.51 |
| Gain, mL min−1 W−1
| ||
| WR 1 | 8.89 ± 0.77 | 10.35 ± 4.64 |
| WR 2 | 8.41 ± 1.27 | 10.13 ± 1.52 |
| WR 3 | 8.33 ± 1.31 | 10.86 ± 2.61 |
| WR 4 | 8.57 ± 1.15 | 10.88 ± 1.36 |
|
| ||
| WR 1 | 0.37 ± 0.09 | 0.21 ± 0.16 |
| WR 2 | 0.27 ± 0.23 | 0.14 ± 0.15 |
| WR 3 | 0.15 ± 0.13 | 0.04 ± 0.10 |
| WR 4 | 0.06 ± 0.11 | 0.00 ± 0.00 |
| End‐exercise | ||
| WR 1 | 2.62 ± 0.57 | 2.63 ± 0.55 |
| WR 2 | 2.71 ± 0.61 | 2.69 ± 0.50 |
| WR 3 | 2.66 ± 0.54 | 2.68 ± 0.48 |
| WR 4 | 2.72 ± 0.40 | 2.71 ± 0.51 |
, fundamental time delay; , fundamental time constant; 95% CI, 95% confidence interval associated with the fundamental time constant; , fundamental amplitude; Absolute , baseline + fundamental amplitude; Gain, increase in fundamental phase per unit increase in power output; , magnitude of the slow component.
Indicates significant main effect of condition,
Indicates significant main effect of work rate (P < 0.05).
Absolute amplitude of the response for WR 3 and 4 in M→S exceeded the value measured at end exercise, therefore, the end exercise is presented.
Figure 2Group mean ± SD critical power (A) and W’ (B) in the unloaded baseline (U→S) and elevated baseline conditions (M→S). The group mean ± SD phase II time constant () and slow component (SC) are overlaid on panels (A) and (B), respectively. Open bars represent group means, whereas dashed black lines represent individual changes in critical power and W’ between conditions. * indicates significant difference between conditions (P < 0.05).
Figure 3Relationship between critical power when normalized to body mass and the time constant of phase II oxygen uptake kinetics (). The correlation was not significant (P > 0.05).
Figure 4Pulmonary oxygen uptake () responses and best‐fit modeled responses of a representative participant in the unloaded baseline (A; U→S) and elevated baseline (B; M→S) conditions. Vertical dashed black lines represent the onset of each step transition. values are displayed for each transition, with the thick gray lines representing the modeled fits. Lines of residuals are displayed at the bottom in gray.
Figure 5Group mean muscle deoxyhemoglobin + myoglobin ([HHb + Mb]) responses and averaged modeled fits to exercise at a single work rate for both muscle sites in the unloaded baseline (open circles) and elevated baseline (black circles) conditions. Responses for the rectus femoris (RF) are displayed in (A), whereas vastus lateralis is displayed in (B). The vertical dashed black line represents the onset of exercise.
Muscle deoxygenation kinetic responses at each power output for both muscle sites in M→S and U→S
| Rectus femoris | Vastus lateralis | |||
|---|---|---|---|---|
| Parameter | U→S | M→S | U→S | M→S |
| [HHb + Mb](b), | ||||
| WR 1 | 19.5 ± 7.1 | 25.7 ± 10.9 | 18.9 ± 6.8 | 19.5 ± 14.9 |
| WR 2 | 19.5 ± 6.8 | 23.6 ± 9.6 | 14.2 ± 9.9 | 18.2 ± 10.3 |
| WR 3 | 19.2 ± 8.9 | 24.4 ± 14.9 | 13.8 ± 7.8 | 19.0 ± 12.8 |
| WR 4 | 18.1 ± 7.5 | 24.3 ± 11.8 | 11.3 ± 8.1 | 20.0 ± 9.3 |
| TD[HHb + Mb], s | ||||
| WR 1 | 6 ± 7 | 19 ± 38 | 4 ± 4 | 37 ± 40 |
| WR 2 | 8 ± 4 | 7 ± 6 | 7 ± 7 | 5 ± 4 |
| WR 3 | 6 ± 5 | 15 ± 27 | 7 ± 4 | 13 ± 24 |
| WR 4 | 6 ± 3 | 10 ± 7 | 6 ± 3 | 27 ± 48 |
|
| ||||
| WR 1 | 15 ± 8 | 55 ± 38 | 11 ± 3 | 38 ± 19 |
| WR 2 | 17 ± 7 | 61 ± 35 | 12 ± 6 | 30 ± 11 |
| WR 3 | 18 ± 8 | 35 ± 17 | 11 ± 4 | 32 ± 29 |
| WR 4 | 21 ± 11 | 42 ± 28 | 12 ± 9 | 22 ± 17 |
|
| ||||
| WR 1 | 7.5 ± 3.7 | 7.5 ± 5.5 | 10.5 ± 7.7 | 6.3 ± 4.6 |
| WR 2 | 7.9 ± 3.6 | 8.2 ± 6.2 | 8.3 ± 6.6 | 7.1 ± 7.9 |
| WR 3 | 9.8 ± 5.0 | 4.4 ± 2.6 | 8.5 ± 7.2 | 5.5 ± 3.7 |
| WR 4 | 8.4 ± 3.4 | 7.1 ± 4.9 | 10.6 ± 8.4 | 4.8 ± 3.1 |
| Absolute | ||||
| WR 1 | 27.0 ± 10.3 | 32.2 ± 15.2 | 29.4 ± 13.6 | 25.8 ± 18.8 |
| WR 2 | 27.4 ± 10.3 | 31.8 ± 13.8 | 22.6 ± 15.8 | 24.4 ± 16.4 |
| WR 3 | 29.1 ± 13.5 | 26.1 ± 15.8 | 22.3 ± 14.6 | 24.5 ± 13.8 |
| WR 4 | 26.5 ± 10.7 | 30.7 ± 15.3 | 23.7 ± 16.4 | 24.8 ± 12.0 |
| SC[HHb + Mb], | ||||
| WR 1 | 4.0 ± 2.7 | 2.3 ± 2.7 | 3.3 ± 2.3 | 0.0 ± 2.1 |
| WR 2 | 2.7 ± 2.0 | 1.2 ± 1.3 | 4.1 ± 8.5 | 2.0 ± 3.3 |
| WR 3 | 1.4 ± 1.7 | 0.0 ± 0.0 | 2.4 ± 3.0 | 0.0 ± 1.4 |
| WR 4 | 0.7 ± 1.2 | 0.0 ± 0.0 | 0.6 ± 0.6 | 0.1 ± 0.6 |
| End‐exercise [HHb + Mb] ( | ||||
| WR 1 | 31.0 ± 11.8 | 34.5 ± 16.4 | 32.7 ± 14.5 | 25.8 ± 18.8 |
| WR 2 | 30.1 ± 11.6 | 33.0 ± 13.5 | 26.7 ± 16.8 | 26.4 ± 18.4 |
| WR 3 | 30.5 ± 14.3 | 26.1 ± 15.8 | 24.7 ± 14.3 | 24.5 ± 13.3 |
| WR 4 | 27.2 ± 10.9 | 30.7 ± 15.3 | 24.3 ± 16.4 | 24.9 ± 12.4 |
| Δ[HHb + Mb]/ | ||||
| WR 1 | 1.16 ± 0.18 | 0.82 ± 0.09 | ||
| WR 2 | 1.05 ± 0.21 | 0.95 ± 0.21 | ||
| WR 3 | 1.09 ± 0.20 | 0.85 ± 0.39 | ||
| WR 4 | 1.21 ± 0.27 | 1.02 ± 0.28 | ||
[HHb + Mb](b), mean [HHb + Mb] over last 30 sec of baseline; TD[HHb + Mb], time delay before exponential rise in [HHb + Mb]; τ [HHb + Mb], time constant of [HHb + Mb] response; A [HHb + Mb], amplitude of [HHb + Mb] response; Absolute A [HHb + Mb], baseline [HHb + Mb] + amplitude [HHb + Mb]; SC[HHb + Mb], magnitude of the [HHb + Mb] slow component; End‐exercise [HHb + Mb], mean [HHb + Mb] during finals 30 s of exercise; Δ[HHb + Mb]/, ratio of Δ[HHb + Mb] to Δ, values presented as means across muscles.
Indicates significant main effect of condition (P < 0.05).
Absolute amplitude of the [HHb + Mb] response for WR 3 and 4 in M→S exceeded the value measured at end exercise, therefore, the end‐exercise [HHb + Mb] is presented. There was no main effect of condition on TD[HHb + Mb], however, in four participants for a total of seven exercise transitions in M→S, there was a long period (i.e., >60 sec) of no change in [HHb + Mb] followed by an exponential increase, thus accounting for the relatively larger mean TD[HHb + Mb] and SD values in M→S.
Figure 6Comparisons of group means ± SD across all work rates and muscle sites for oxyhemoglobin (A; [HbO2 + MbO2]) and total hemoglobin (B; [THb + Mb]) between conditions. Open circles, unloaded baseline condition (U→S); closed circles, elevated baseline condition, (M→S). No significant differences were observed between conditions for either variable (P > 0.05).